SANA BIOTECHNOLOGY INC
SANA BIOTECHNOLOGY INC is a biotechnology company focused on the development and commercialization of revolutionary medicines.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying SANA Biotechnology's stock with a target price of $10.8, indicating growth potential.
Financial Health
SANA Biotechnology is maintaining a reasonable financial position with steady cash flow and book value.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring SANA
Hope & Optimism Portfolio
This collection brings together pioneering companies working to solve humanity's biggest challenges through groundbreaking innovation. These carefully selected stocks represent visionaries building transformative technologies in medicine, energy, and beyond.
Published: June 18, 2025
Explore BasketAge-Reversal Biotech
Invest in pioneering companies that are redefining aging as a treatable condition. These carefully selected biotechs are developing groundbreaking therapies to extend healthy lifespans and potentially reverse cellular damage, creating an entirely new frontier in medicine.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Pipeline Catalysts Ahead
Several clinical readouts and preclinical milestones could materially affect valuation, though outcomes are uncertain and performance can vary.
Platform Innovation Focus
Sana’s in vivo and ex vivo platforms aim to improve delivery and manufacturability, which may offer competitive advantages but are not guaranteed to produce approved therapies.
Partnerships and Scale
Collaborations and manufacturing scale-up can derisk development and expand reach, yet they require capital and regulatory alignment and may take time.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals develops treatments for diseases including cystic fibrosis and cancer.
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals is a leading biotechnology company that develops and manufactures innovative medicines for serious medical conditions.
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics based on RNA interference (RNAi).
